165 related articles for article (PubMed ID: 8673007)
1. Inhibition of Helicobacter pylori urease activity by ebrotidine.
Piotrowski J; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
4. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
[TBL] [Abstract][Full Text] [Related]
6. In vitro anti-Helicobacter pylori activity of ebrotidine.
Palacín C; Tarragó C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
[TBL] [Abstract][Full Text] [Related]
7. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
[TBL] [Abstract][Full Text] [Related]
8. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
Piotrowski J; Morita M; Slomiany A; Slomiany BL
Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
[TBL] [Abstract][Full Text] [Related]
10. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
11. Ebrotidine.
Patel SS; Wilde MI
Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
Nomura S; Suzuki H; Masaoka T; Kurabayashi K; Ishii H; Kitajima M; Nomoto K; Hibi T
Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
[TBL] [Abstract][Full Text] [Related]
14. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
[TBL] [Abstract][Full Text] [Related]
15. Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.
Aristoteli LP; O'Rourke JL; Danon S; Larsson H; Mellgard B; Mitchell H; Lee A
Helicobacter; 2006 Oct; 11(5):460-8. PubMed ID: 16961809
[TBL] [Abstract][Full Text] [Related]
16. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
Slomiany BL; Piotrowski J; Murty VL; Slomiany A
Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
[TBL] [Abstract][Full Text] [Related]
19. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
Slomiany BL; Lopez RA; Slomiany A
Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
